175 related articles for article (PubMed ID: 20682592)
21. Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass.
Stomper PC; Geradts J; Edge SB; Levine EG
AJR Am J Roentgenol; 2003 Dec; 181(6):1679-84. PubMed ID: 14627596
[TBL] [Abstract][Full Text] [Related]
22. Mammographic and sonographic findings of primary breast lymphoma.
Lyou CY; Yang SK; Choe DH; Lee BH; Kim KH
Clin Imaging; 2007; 31(4):234-8. PubMed ID: 17599616
[TBL] [Abstract][Full Text] [Related]
23. BI-RADS 3-5 microcalcifications: prediction of lymph node metastasis of breast cancer.
Cen D; Xu L; Zhang S; Zhou S; Huang Y; Chen Z; Li N; Wang Y; Wang Q
Oncotarget; 2017 May; 8(18):30190-30198. PubMed ID: 28415815
[TBL] [Abstract][Full Text] [Related]
24. [Our surgical indication for breast-conserving therapy for breast cancer--special reference to extensive intraductal component and mammographic calcifications].
Takashima S; Doihara H; Saeki T; Mandai K; Kataoka M
Gan To Kagaku Ryoho; 1994 Jun; 21 Suppl 2():190-6. PubMed ID: 8037481
[TBL] [Abstract][Full Text] [Related]
25. Mammographic casting-type calcification associated with small screen-detected invasive breast cancers: is this a reliable prognostic indicator?
Peacock C; Given-Wilson RM; Duffy SW
Clin Radiol; 2004 Feb; 59(2):165-70; discussion 163-4. PubMed ID: 14746787
[TBL] [Abstract][Full Text] [Related]
26. Can the clinical and mammographic findings at presentation predict the presence of an extensive intraductal component in early stage breast cancer?
Healey EA; Osteen RT; Schnitt SJ; Gelman R; Stomper PC; Connolly JL; Harris JR
Int J Radiat Oncol Biol Phys; 1989 Dec; 17(6):1217-21. PubMed ID: 2557306
[TBL] [Abstract][Full Text] [Related]
27. Tumor characteristics in screen-detected and symptomatic breast cancers.
Pálka I; Kelemen G; Ormándi K; Lázár G; Nyári T; Thurzó L; Kahán Z
Pathol Oncol Res; 2008 Jun; 14(2):161-7. PubMed ID: 18347932
[TBL] [Abstract][Full Text] [Related]
28. Quantitative apparent diffusion coefficient measurement obtained by 3.0Tesla MRI as a potential noninvasive marker of tumor aggressiveness in breast cancer.
Durando M; Gennaro L; Cho GY; Giri DD; Gnanasigamani MM; Patil S; Sutton EJ; Deasy JO; Morris EA; Thakur SB
Eur J Radiol; 2016 Sep; 85(9):1651-8. PubMed ID: 27501902
[TBL] [Abstract][Full Text] [Related]
29. Sonographic and pathological features of metaplastic squamous cell carcinoma of the breast: a case series.
Ye XJ; Chen XY; Ke ZB; Lin F; Wu YP; Yan L
BMC Surg; 2021 Oct; 21(1):374. PubMed ID: 34688286
[TBL] [Abstract][Full Text] [Related]
30. Nonpalpable breast cancer: mammographic appearance as predictor of histologic type.
Thurfjell MG; Lindgren A; Thurfjell E
Radiology; 2002 Jan; 222(1):165-70. PubMed ID: 11756721
[TBL] [Abstract][Full Text] [Related]
31. Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study.
Fajardo LL; Pisano ED; Caudry DJ; Gatsonis CA; Berg WA; Connolly J; Schnitt S; Page DL; McNeil BJ;
Acad Radiol; 2004 Mar; 11(3):293-308. PubMed ID: 15035520
[TBL] [Abstract][Full Text] [Related]
32. Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression.
Wang Y; Ikeda DM; Narasimhan B; Longacre TA; Bleicher RJ; Pal S; Jackman RJ; Jeffrey SS
Radiology; 2008 Feb; 246(2):367-75. PubMed ID: 18180338
[TBL] [Abstract][Full Text] [Related]
33. Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer.
Huang HJ; Neven P; Drijkoningen M; Paridaens R; Wildiers H; Van Limbergen E; Berteloot P; Amant F; Vergote I; Christiaens MR
J Clin Pathol; 2005 Jun; 58(6):611-6. PubMed ID: 15917412
[TBL] [Abstract][Full Text] [Related]
34. The association between mammographic calcifications and breast cancer prognostic factors in a population-based registry cohort.
Nyante SJ; Lee SS; Benefield TS; Hoots TN; Henderson LM
Cancer; 2017 Jan; 123(2):219-227. PubMed ID: 27683209
[TBL] [Abstract][Full Text] [Related]
35. [Mammographic and pathological features of triple-negative breast cancer].
Wen SY; Han YW; Ma XM; Zhang J; Cui WJ; Cao XC; Wang X
Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):291-5. PubMed ID: 22781043
[TBL] [Abstract][Full Text] [Related]
36. Negative estrogen-receptor invasive breast carcinoma: mammographic aspects, correlations with HER2/neu oncoprotein status.
Enache DE; Georgescu CV; Pătrană N
Rom J Morphol Embryol; 2012; 53(3 Suppl):755-62. PubMed ID: 23188436
[TBL] [Abstract][Full Text] [Related]
37. Mammography, US, and MRI to Assess Outcomes of Invasive Breast Cancer with Extensive Intraductal Component: A Matched Cohort Study.
Ha SM; Cha JH; Shin HJ; Chae EY; Choi WJ; Kim HH
Radiology; 2019 Aug; 292(2):299-308. PubMed ID: 31135297
[TBL] [Abstract][Full Text] [Related]
38. [Critical review of 215 cases of non-palpable mammary lesions].
Pastore G; Marano P; Romani M; Costantini M; Belli P
Radiol Med; 1999 May; 97(5):344-8. PubMed ID: 10432964
[TBL] [Abstract][Full Text] [Related]
39. Mammographic and clinicopathological features of mucinous carcinoma of the breast.
Matsuda M; Yoshimoto M; Iwase T; Takahashi K; Kasumi F; Akiyama F; Sakamoto G
Breast Cancer; 2000 Jan; 7(1):65-70. PubMed ID: 11029773
[TBL] [Abstract][Full Text] [Related]
40. Is the presence of mammographic comedo calcification really a prognostic factor for small screen-detected invasive breast cancers?
James JJ; Evans AJ; Pinder SE; Macmillan RD; Wilson AR; Ellis IO
Clin Radiol; 2003 Jan; 58(1):54-62. PubMed ID: 12565206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
